A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products

The aim of the study is to obtain an understanding of relevant parameters affecting the performance of ostomy products.

Study Overview

• Status: Completed
• Conditions: Ileostomy - Stoma; Colostomy
• Intervention / Treatment: Device: SenSura Mio Convex Soft

Detailed Description

72 subjects will be included. Each subject will attend 3 visits at the clinic/hospital or at the subjects home depending on the final site set-up. Each subject will be enrolled for 14 weeks in total for the entire investigation.

Coloplast will provide SenSura Mio Convex Soft for all subjects via the investigator. Based on the subjects' usual changing pattern, the investigator will provide the subjects with enough products for the whole test period.

The subject will answer questions regarding the tested products by filling out the subject part in the eCRF daily. The subject will answer questions using an electronic device and use the device to take pictures of the peristomal skin and used products at each product change. The Investigator fills out the investigator part of the eCRF at each visit. The subjects must complete the general questions at the end of each test period before their second and third visit at the Clinic/hospital or at home to avoid influence by the investigator.

The use of accessories will be noted in the eCRF. Samples of biological material will not be taken or used in this investigation. Patient files from own physician will not be used for subjects recruited via a Coloplast's database. The investigators may use patient files for subjects recruited via hospital sites/ostomy clinics to identifying relevant subjects and/or to verify baseline information, concomitant medication or adverse events. To be able to fulfil the objectives, the investigation must include both ileostomists and colostomists.

• Study Type: Interventional
• Enrollment (Actual): 74
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Netherlands
  • Groningen, Netherlands, 9713
    • QPS Netherlands
• Norway
  • Larvik, Norway, 3269
    • Helse Nordbyen
• United Kingdom
  • Birmingham, United Kingdom, B15 2SQ
    • Synexus Midlands
  • Boston, United Kingdom
    • Pilgrim Hospital
  • Cheltenham, United Kingdom, G1537AN
    • Cheltenham General Hospital
  • Kettering, United Kingdom, NN168UZ
    • Kettering General Hospital
  • Lincoln, United Kingdom, LN25QY
    • Lincon Country hospital
• United States
  • Illinois
    • Chicago, Illinois, United States, 60637
      • University of Chicago Medicine
  • Minnesota
    • Saint Paul, Minnesota, United States, 55114
      • PRISM Research Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Have given written informed consent
• Be at least 18 years of age and have full legal capacity
• Have an ileostomy or colostomy
• Have had their ostomy for at least 3 months
• Must use 1 piece open or closed ostomy products during the test period
• Currently using a 1 piece. flat product
• Must be able to use custom cut product
• Have intact peristomal skin
• Has experienced leakage (seeping) under the baseplate at least three times during the last two weeks
• Are evaluated to be suitable for a soft convex product

Exclusion Criteria:

• Currently receiving or have within the past 2 month received radio- and/or chemotherapy
• Currently or having within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
• Are pregnant or breastfeeding
• Participating in other interventional clinical investigations or have previously participated in this investigation

Study Plan

How is the study designed?

Design Details

• Primary Purpose: BASIC_SCIENCE
• Allocation: NA
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Test period; The arm consists of a two-week baseline period where subjects apply their own product and a 12 weeks test period where the subjects apply the intervention (SenSura Mio Convex Soft)	Device: SenSura Mio Convex Soft; SenSura Mio Convex Soft is a CE marked ostomy product manufactured by Coloplast

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Leakage Under the Baseplate (cm^2)	The leakage area was measured using photos of used baseplates. A computer program was used to measure the leakage area.	14 weeks (2 weeks baseline + 12 weeks intervention)

Collaborators and Investigators

• Sponsor: Coloplast A/S
• Investigators: Study Chair: Camilla F Vibjerg, M.Sc.pharm, Head of Clinical Operations

Study record dates

Study Major Dates

• Study Start: September 1, 2015
• Primary Completion (Actual): March 1, 2016
• Study Completion (Actual): March 1, 2016

Study Registration Dates

• First Submitted: August 5, 2015
• First Submitted That Met QC Criteria: August 5, 2015
• First Posted (Estimate): August 7, 2015

Study Record Updates

• Last Update Posted (Actual): November 16, 2022
• Last Update Submitted That Met QC Criteria: November 15, 2022
• Last Verified: November 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: CP259